TP3011(Synonyms: CH0793011)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

TP3011 (Synonyms: CH0793011)

TP3011 (CH0793011) 是 CH-0793076 的活性代谢产物 (metabolite)，是与 SN38 等价的有效拓扑异构酶 I (topoisomerase I) 抑制剂。TP3011 在 IC50 亚纳摩尔范围内可抵抗癌细胞系的生长。

TP3011(Synonyms: CH0793011)

TP3011 Chemical Structure

CAS No. : 534605-74-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

TP3011 (CH0793011) is an active metabolite of CH-0793076 and is a potent topoisomerase I inhibitor equipotent as SN38[1]. TP3011 is against cancer cell lines growth with IC50s at the range sub-nanomolar in vitro[2].

IC50 & Target[1]

Topoisomerase I

 

体外研究
(In Vitro)

TP3011 (0-100 nM; 72 hours) (compound 6c) inhibits cell proliferative activities against various human cancer cell lines, producing 50% inhibition (IC50) of cell growth of 0.85 nM; 8.5 nM; and 8.2 nM in HCT116, QG56, and NCI-H460 (NSCLC) cells, respectively[2].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[2]

Cell Line: HCT116, QG56, and NCI-H460 (NSCLC) cells
Concentration: 0-100 nM
Incubation Time: 72 hours
Result: Was against human cancer cell lines, such as CRC and NSCLC cell lines.

分子量

474.51

Formula

C26H26N4O5
CAS 号

534605-74-8
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Anthoney DA, et al. Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses.BMC Cancer. 2012 Nov 21;12:536.

    [2]. Niizuma S, et al. Synthesis of new camptothecin analogs with improved antitumor activities.Bioorg Med Chem Lett. 2009 Apr 1;19(7):2018-21.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

发表回复